The rate of new molecule introductions has declined. The costs to bring a new molecule to market have risen from U.S. $152 million in 1995 to $256 million in 2005, as the number of compounds synthesized to deliver one new market introduction rose from 52,500 in 1995 to 140,000 in 2005.[1]